<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02788396</url>
  </required_header>
  <id_info>
    <org_study_id>B853</org_study_id>
    <nct_id>NCT02788396</nct_id>
  </id_info>
  <brief_title>The Impact of Post Stenting Balloon Dilatation on Coronary Microcirculation in STEMI Patients Undergoing PPCI</brief_title>
  <acronym>POSTDILSTEMI</acronym>
  <official_title>The Impact of Post Stenting Balloon Dilatation on Coronary Microcirculation in ST Segment Elevation Myocardial Infarction (STEMI) Patients Undergoing Primary Percutaneous Coronary Intervention (PPCI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Basildon and Thurrock University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Anglia Ruskin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Basildon and Thurrock University Hospitals NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess the impact of NC balloon post-dilatation on coronary
      microcirculation in patients with ST segment elevation myocardial infarction (STEMI)
      undergoing primary percutaneous coronary intervention (PPCI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Suboptimal stent deployment can lead to future stent failure. Thus, optimising stent
      deployment with non-compliant balloons (NC balloon) post dilatation (PD) at high pressures is
      an established strategy. In the context of ST segment elevation myocardial infarction
      (STEMI), PD has been correlated anecdotally with the no reflow phenomenon.

      This study aims to determine the impact of stent post-dilation (PD) with NC balloons at high
      pressures on coronary microcirculation during PPCI by measuring the index of microcirculatory
      resistance (IMR) pre and post stent post-dilatation. Pre and post PD, an optical coherence
      tomography (OCT) study will be performed to assess stent deployment and identify parameters
      that predict the changes in IMR.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Delta index of microcirculatory resistance (dIMR)</measure>
    <time_frame>index procedure</time_frame>
    <description>Delta index of microcirculatory resistance (dIMR) [dΙΜΡ = IMR post post-dilation (post IMR) - IMR pre post-dilation (pre IMR)]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Minimum stent area (MSA)</measure>
    <time_frame>index procedure</time_frame>
    <description>Pre and post dilatation minimum stent area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent expansion</measure>
    <time_frame>index procedure</time_frame>
    <description>Pre and post dilatation stent expansion; defined as the minimum stent area divided by the average of proximal and distal reference lumen areas x 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent mal-apposition</measure>
    <time_frame>index procedure</time_frame>
    <description>Stent mal-apposition pre and post dilatation; defined as a distance between the strut's luminal edge and luminal vessel wall of greater &gt;200 μm for a length &gt;600 μm (appreciable in &gt;3 contiguous frames at a pull-back speed of 20 mm/sec</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-stent plaque protrusion and thrombus</measure>
    <time_frame>index procedure</time_frame>
    <description>Pre and post dilatation intra-stent plaque protrusion and thrombus; defined as a mass attached to the luminal surface or floating within the lumen at least 200 μm beyond the luminal edge of a strut</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent edge dissections</measure>
    <time_frame>index procedure</time_frame>
    <description>Edge dissections pre and post dilatation, further defined as major and minor [major dissections defined as the ones with a dissection flap width greater or equal to 200 μm)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>ST-elevation Myocardial Infarction (STEMI)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        STEMI patients undergoing PPCI
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  &gt;18 years of age

          -  Acute symptoms onset with duration &gt; 20 minutes

          -  ST-segment elevation ≥ 0.1 mV in ≥ 2 contiguous leads, signs of a true posterior
             infarction or documented newly developed left bundle branch block

          -  Infarct related artery with a diameter above 2.5 mm

          -  Operator's intention to proceed to stent deployment (i.e. not refer for CABG or defer
             PCI)

        Exclusion Criteria

          -  &lt; 18 year of age

          -  Symptoms duration &gt; 12 hours

          -  Unable to give informed consent

          -  Previous bypass graft surgery

          -  Previous myocardial infarction

          -  Pregnancy

          -  Known severe chronic kidney disease (creatinine clearance ≤30 mL/min), unless the
             patient is on dialysis

          -  Unable to receive antiplatelets or anticoagulation (i.e. coagulation disorders,
             bleeding etc.)

          -  Haemodynamic instability

          -  Severe LMS disease

          -  Culprit vessel diameter &lt; 2.5 mm

          -  Contraindications to adenosine

          -  Any study lesion characteristic resulting in the expected inability to deliver OCT
             catheter to the lesion pre and post PD (e.g. moderate or severe vessel calcification
             or tortuosity)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John R Davies, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Basildon and Thurrock University Hospitals NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John R Davies, MD PhD</last_name>
    <phone>01268524900</phone>
    <email>john.davies@btuh.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Grigoris V Karamasis, MD</last_name>
    <phone>01268524900</phone>
    <email>grigoris.karamasis@btuh.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Essex Cardiothoracic Centre</name>
      <address>
        <city>Basildon</city>
        <state>Essex</state>
        <zip>SS16 5NL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grigoris V Karamasis, MD</last_name>
      <phone>01268524900</phone>
      <email>grigoris.karamasis@btuh.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Carol L Alves, BSc MRes</last_name>
      <phone>08451551111</phone>
      <phone_ext>3599</phone_ext>
      <email>carol.alves@btuh.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>John R Davies, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grigoris V Karamasis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas R Keeble, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2016</study_first_submitted>
  <study_first_submitted_qc>May 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2016</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>STEMI</keyword>
  <keyword>PPCI</keyword>
  <keyword>post-dilatation</keyword>
  <keyword>coronary microcirculation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

